Patents by Inventor Wilfried Wormsbacher

Wilfried Wormsbacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY
    Publication number: 20140248686
    Abstract: The present invention relates to the field of modified therapeutic polypeptides with increased in vivo recovery compared to their non-modified parent polypeptide. For example, the invention relates to fusions of therapeutic polypeptides with recovery enhancing polypeptides connected directly or optionally connected by a linker peptide.
    Type: Application
    Filed: March 27, 2014
    Publication date: September 4, 2014
    Applicant: CSL Behring GMBH
    Inventors: Thomas Weimer, Hubert Metzner, Stefan Schulte, Wiegand Lang, Wilfried Wormsbacher
  • THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY
    Publication number: 20130337532
    Abstract: The present invention relates to the field of modified therapeutic polypeptides with increased in vivo recovery compared to their non-modified parent polypeptide. For example, the invention relates to fusions of therapeutic polypeptides with recovery enhancing polypeptides connected directly or optionally connected by a linker peptide.
    Type: Application
    Filed: June 19, 2013
    Publication date: December 19, 2013
    Applicant: CSL BEHRING GMBH
    Inventors: Thomas Weimer, Hubert Metzner, Stefan Schulte, Wiegand Lang, Wilfried Wormsbacher
  • Agent for the therapy of factor VIII-resistant hemophilia A, and a process for the preparation thereof
    Patent number: 5091363
    Abstract: An agent for the therapy of hemophilia A which is resistant to treatment with factor VIII is described, and is obtainable by maintaining a mixture of factor VIII, antithrombin III, a phospholipid and calcium ions in an aqueous solution at a temperature of from 1.degree. to 45.degree. C. for at least one minute, adding factor IX, and maintaining the solution at a temperature offrom 1.degree. to 45.degree. C. until addition of a sample of this solution to an inhibitor plasma results in a partial thromboplastin time (PTT) of 15 to 30 seconds, where appropriate adding a polyol and, where appropriate, an amino acid, and, where appropriate, drying the solution.
    Type: Grant
    Filed: August 10, 1988
    Date of Patent: February 25, 1992
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Norbert Heimburger, Karlheinz Wenz, Wilfried Wormsbacher
  • Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
    Patent number: 5043428
    Abstract: A process for the production of a preparation of blood coagulation factor VIII which makes it possible to obtain a pasteurized product which is virtually free of immunoglobulins, isoagglutinins, fibronectin and coagulable fibrinogen is described.A product of this type can be used for the treatment of blood coagulation disturbances.
    Type: Grant
    Filed: June 18, 1990
    Date of Patent: August 27, 1991
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Norbert Heimburger, Wilfried Wormsbacher, Gerhardt Kumpe
  • Pasteurized human fibrinogen (HF), a process for its preparation, and its use
    Patent number: 4960757
    Abstract: A pasteurized human firbinogen which can be used therapeutically, and a process for its preparation are described.
    Type: Grant
    Filed: August 1, 1988
    Date of Patent: October 2, 1990
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Gerhardt Kumpe, Wilfried Wormsbacher, Norbert Heimburger, Peter Fuhge, Hans M. Preis
  • Process for the pasteurization of human residual plasma
    Patent number: 4579735
    Abstract: A process for the preparation of a pasteurized human citrated plasma is described, in which citrated plasma, from which the prothrombin factors and labile proteins have been removed, is heated in the presence of stabilizers.
    Type: Grant
    Filed: August 24, 1984
    Date of Patent: April 1, 1986
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Norbert Heimburger, Hermann E. Karges, Gerhardt Kumpe, Wilfried Wormsbacher
  • Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby
    Patent number: 4562072
    Abstract: A process for the pasteurization of antihemophilic cryoprecipitate (AHC) is described, wherein AHC is heated in the presence of calicum ions, an amino acid and a carbohydrate. The pasteurized AHC is used for the treatment of coagulation disturbances.
    Type: Grant
    Filed: October 7, 1983
    Date of Patent: December 31, 1985
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Norbert Heimburger, Gerhardt Kumpe, Wilfried Wormsbacher, Hans M. Preis
  • Method for rendering factors IX and X hepatitis-safe with calcium ions
    Patent number: 4405603
    Abstract: What is disclosed is a method for making a preparation containing blood clotting Factors IX and/or X virtually hepatitis-safe by warming said peparation in the presence of calcium ions and in the further presence of an amino acid and/or a saccharide or sugar alcohol.
    Type: Grant
    Filed: November 25, 1981
    Date of Patent: September 20, 1983
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Horst Schwinn, Norbert Heimburger, Gerhardt Kumpe, Wilfried Wormsbacher